8 Results for "

Short bowel syndrome

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "Short bowel syndrome" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P3291
CAS No.: 2296814-85-0
Synonyms: ZP7570
Target:  

GCGR

Research Areas:  

Metabolic Disease

Dapiglutide (ZP7570) is a long-acting glucagon-like peptide-1 receptor 1R (GLP-1R)/Glucagon-like peptide-2 receptor (GLP-2R) dual agonist. Dapiglutide alleviates intestinal dysfunction in a mouse short bowel model and has anti-obesity effects .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P2221
CAS No.: 914009-86-2
Synonyms: ZP1848
Target:  

GCGR

Research Areas:  

Inflammation/Immunology

Glepaglutide (ZP1848), a long-acting GLP-2 analogue, is a potent GLP-2R agonist. Glepaglutide reduces faecal output and increases intestinal absorption. Glepaglutide alleviates small intestinal inflammation. Glepaglutide can be used in the research of inflammatory bowel disease (IBD) and Crohn’s disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N5139
CAS No.: 93685-90-6
Synonyms: Lecithins, egg yolk; Belovo PL 85
Lecithins, egg (Lecithins, egg yolk; Belovo PL 85) is an orally active natural phospholipid mixture extracted from egg yolks . Lecithins, egg inhibits the activities of acetylcholinesterase (AChE) and angiotensin-converting enzyme (ACE). Lecithins, egg exhibits antibacterial, antioxidant and anti-inflammatory activities, and helps delay cellular senescence. Lecithins, egg enhances nerve conduction, improves memory and cognitive function, and exerts positive effects on delaying neurodegenerative diseases. Lecithins, egg promotes lipid absorption and alleviates diarrhea. Lecithins, egg acts as a high-efficiency drug carrier for the preparation of targeted drug delivery systems such as liposomes .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P2221B
Synonyms: ZP1848 acetate
Target:  

GCGR

Research Areas:  

Inflammation/Immunology

Glepaglutide (ZP1848) acetate, a long-acting GLP-2 analogue, is a potent GLP-2R agonist. Glepaglutide acetate reduces faecal output and increases intestinal absorption. Glepaglutide acetate alleviates small intestinal inflammation. Glepaglutide acetate can be used in the research of inflammatory bowel disease (IBD) and Crohn’s disease .
loading...
    loading...
Cat. No.: HY-111095B
CAS No.: 920-49-0
Purity:  ≥98.0%
Synonyms: (R)-2-Hydroxypropionic acid sodium
D-(-)-Lactic acid ((R)-2-Hydroxypropionic acid) sodium is an orally active, toxic optical isomer of Lactic acid (HY-B2227), mainly derived from overproduction by intestinal bacteria or exogenous intake. D-(-)-Lactic acid sodium can induce intoxication, characterized by severe metabolic acidosis accompanied by neurological symptoms .
loading...
    loading...
Cat. No.: HY-P1714
CAS No.: 1295353-98-8
Synonyms: FE 203799
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

Apraglutide (FE 203799), a synthetic 33-amino-acid peptide and a long-acting GLP-2 analogue, enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum .
loading...
    loading...
Cat. No.: HY-P1714A
Synonyms: FE 203799 TFA
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

Apraglutide TFA (FE 203799 TFA), a synthetic 33-amino-acid peptide and a long-acting GLP-2 analogue, enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum .
loading...
    loading...
Cat. No.: HY-P3389
CAS No.: 2434640-83-0

Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

Vurolenatide is a long-lasting GLP-1 analogue. Vurolenatide can be studied in research on short bowel syndrome .
loading...
    loading...